Raymond James & Associates’s Amsurg Corp AMSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-435,320
Closed -$29.2M 3451
2016
Q3
$29.2M Buy
435,320
+170,634
+64% +$11.9M 0.08% 248
2016
Q2
$20.5M Sell
264,686
-12,509
-5% -$967K 0.06% 303
2016
Q1
$20.7M Buy
277,195
+3,326
+1% +$234K 0.07% 301
2015
Q4
$20.8M Buy
273,869
+152,197
+125% +$12.1M 0.07% 301
2015
Q3
$9.46M Sell
121,672
-766
-0.6% -$59.1K 0.04% 501
2015
Q2
$8.56M Buy
122,438
+46,266
+61% +$3.09M 0.03% 576
2015
Q1
$4.69M Buy
76,172
+27,065
+55% +$1.56M 0.02% 774
2014
Q4
$2.69M Sell
49,107
-3,905
-7% -$199K 0.01% 1002
2014
Q3
$2.65M Buy
+53,012
New +$2.65M 0.02% 947

Other funds holding AMSG

Raymond James & Associates's AMSG Position: Q4 2016 in Review

Raymond James & Associates sold out of Amsurg Corp (AMSG) in Q4 2016, closing a stake of 435,320 shares — an estimated $29.2M sold.

Raymond James & Associates first reported a position in AMSG in Q3 2014 and held it in 9 quarters. The position peaked at $29.2M in Q3 2016. 7 funds tracked by Wall St. Rank hold AMSG as of Q4 2016.

  • Raymond James & Associates reported no remaining Amsurg Corp position as of Q4 2016 after selling out during the quarter.
  • Raymond James & Associates sold 435,320 Amsurg Corp shares in Q4 2016, an estimated $29.2M.
  • Raymond James & Associates first reported a position in Amsurg Corp in Q3 2014 and held it in 9 quarters.
  • Raymond James & Associates's Amsurg Corp position peaked at $29.2M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Amsurg Corp as of Q4 2016.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.